March 19, 2025
TOPLINE: The introduction of highly effective modulator (elexacaftor/tezacaftor/ivacaftor) therapy improved the disease trajectory of cystic fibrosis (CF). However, its benefits were less pronounced for lung transplant […]
March 18, 2025
TOPLINE: Dupilumab reduced airway inflammation and mucus burden and enhanced airway volume and flow, which led to better lung function and improved asthma control in patients […]
March 17, 2025
TOPLINE: Antibody responses to the O-specific polysaccharide of Klebsiella pneumoniae were immunogenic, with cross-reactivity among related subtypes; however, capsule interference with O-specific polysaccharide antibody binding highlighted […]
March 17, 2025
The evidence that glucose-lowering medications can improve symptoms of chronic obstructive pulmonary disease (COPD) in people with diabetes has been growing, but a few studies, including […]
March 12, 2025
FLORENCE, Italy — Exacerbations remain one of the major unresolved challenges in the management of chronic obstructive pulmonary disease (COPD), despite the introduction of new therapies. […]
March 11, 2025
Adult cancer survivors in the United States were more likely to report severe COVID-19 symptoms compared to the general population, based on data from a new […]
March 10, 2025
Infection control became a challenge among the children sheltering during the Los Angeles County fires this past January, said a public health expert on site at […]
March 10, 2025
SAN DIEGO — Several studies presented here at the American Academy of Allergy, Asthma, & Immunology (AAAAI)/World Allergy Organization 2025 Annual Meeting solidify the case that […]
March 10, 2025
SAN DIEGO — Asthma afflicts 8.1% of school-age children in the United States and is a leading cause of missed school and work. Having stock inhalers […]